Job Description
Drive early-phase biomarker and therapeutic-target discovery across oncology, organ-health, and women’s-health programs. Partner with other bioinformaticians, clinical AI scientists, wet-lab scientists, clinicians, and data engineers to design and implement robust multi-omics analyses, produce clear data visualizations, and translate findings into actionable insights that shape our next-generation assays and therapeutics.
Develop & enhance analytic pipelines for DNA-, RNA-, and epigenomic sequencing (short- and long-read) covering somatic, germline, expression, and methylation data. Integrate heterogeneous datasets (bulk & single-cell genomics, proteomics, clinical metadata) to reveal biomarkers and novel drug-target hypotheses. Prototype and benchmark new algorithms (e.g., variant calling, expression deconvolution, pathway/network analysis); establish gold-standard datasets and QC metrics. Automate workflows to improve speed, reproducibility, and scalability in a regulated environment; document and release production-quality code. Collaborate with R&D stakeholders to refine requirements, interpret results, and iterate on study designs across oncology, transplant/organ health, and women’s reproductive health. Generate clear reports and visualizations for internal review, manuscripts, regulatory submissions, and conference presentations. Contribute to external partnerships and cross-functional research projects; stay current on emerging bioinformatic methods and public datasets.
About Natera
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.